Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Approaches to the Management of Patients with Endometrial Cancer
Emmanouil Kalampokas, Georgios Giannis, Theodoros Kalampokas, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4500-4500
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 23, pp. 2145-2158
Open Access | Times Cited: 489
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial
M.A. Powell, Line Bjørge, Lyndsay Willmott, et al.
Annals of Oncology (2024) Vol. 35, Iss. 8, pp. 728-738
Open Access | Times Cited: 27
Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis
Mohd Nazzary Mamat Yusof, Kah Teik Chew, Abdul Muzhill Hannaan Abdul Hafizz, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4032-4032
Open Access | Times Cited: 18
SIRT1-mediated deacetylation of FOXO3 enhances mitophagy and drives hormone resistance in endometrial cancer
Wei Xue-hua, Xiangpeng Xiong, Pingping Wang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 6
Exploring the Potential Link between PFAS Exposure and Endometrial Cancer: A Review of Environmental and Sociodemographic Factors
A. E. Ayodele, Emmanuel Obeng-Gyasi
Cancers (2024) Vol. 16, Iss. 5, pp. 983-983
Open Access | Times Cited: 5
Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications
Kiavash Hushmandi, Daniel J. Klionsky, Amir Reza Aref, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1159-1177
Open Access | Times Cited: 5
Sentinel lymph node biopsy in endometrial cancer: When, how and in which patients
Umberto Leone Roberti Maggiore, Ludovica Spanò Bascio, Carlo Alboni, et al.
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 3, pp. 107956-107956
Closed Access | Times Cited: 4
Therapeutic potential of Curcuma oil and its terpenoids in gynecological cancers
Yuan Zhang, Fu Peng, Chenghao Yu
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114016-114016
Open Access | Times Cited: 18
Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials
Ji Ren, Jinghe Wang, Yanan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Unravelling the mystique of recurrence: A comparative analysis of surgical approaches for early-stage endometrial cancer
Priya Bhati, Monal Garg, Divya Panyam Vuppu, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2025) Vol. 308, pp. 70-77
Closed Access
Gene expression and soluble protein level of PD-1 and its ligands (PD-L1 and PD-L2) in endometrial cancer
Mohd Nazzary Mamat Yusof, Kah Teik Chew, Nirmala Chandralega Kampan, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0312765-e0312765
Open Access
Factors affecting the postoperative survival rate of obese Asian patients with endometrial cancer
Huiqiao Gao, Lu Qi, Jianxin Zhang
Journal of Obstetrics and Gynaecology (2025) Vol. 45, Iss. 1
Open Access
A brief review of Lynch syndrome: understanding the dual cancer risk between endometrial and colorectal cancer
Sneha Pallatt, Sibin Nambidi, Subhamay Adhikary, et al.
Oncology Reviews (2025) Vol. 19
Open Access
Anti-cancer activity of capsaicin and its analogs in gynecological cancers
Kathleen C. Brown, Amanda M. Sugrue, Kaitlyn Conley, et al.
Advances in cancer research (2024), pp. 241-281
Closed Access | Times Cited: 3
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Matthew A. Powell, David Cibula, David M. O’Malley, et al.
Gynecologic Oncology (2024) Vol. 192, pp. 40-49
Closed Access | Times Cited: 3
Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance
Meiying Qin, Chunmei Zhang, Li Yang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Visualization Methods for Uterine Sentinel Lymph Nodes in Early-Stage Endometrial Carcinoma: A Comparative Analysis
Linas Andreika, Karolina Vankevičienė, Diana Ramašauskaitė, et al.
Diagnostics (2024) Vol. 14, Iss. 5, pp. 552-552
Open Access | Times Cited: 2
Diagnostic utility of apparent diffusion coefficient in preoperative assessment of endometrial cancer: are we ready for the 2023 FIGO staging?
Gehad A. Saleh, Rasha Abdelrazek, Amany Hassan, et al.
BMC Medical Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Characterization and Clinical Relevance of Endometrial CAFs: Correlation between Post-Surgery Event and Resistance to Drugs
Raed Sulaiman, Pradip De, Jennifer C. Aske, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6449-6449
Open Access | Times Cited: 5
Cost-effectiveness analysis of dostarlimab plus carboplatin-paclitaxel as first-line treatment for advanced endometrial cancer
Maojin You, Xiaoling Zeng, Jinrong Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
A meta‐analysis of the risk factors of surgical site infection after hysterectomy for endometrial cancer
Rong Yang, Lu Wang, Chengyu Shui
International Wound Journal (2023) Vol. 21, Iss. 2
Open Access | Times Cited: 5
Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence
Jesús González Bosquet, Sofia Gabrilovich, Megan McDonald, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16014-16014
Open Access | Times Cited: 8
Cadmium, Lead, Chronic Physiological Stress and Endometrial Cancer: How Environmental Policy Can Alter the Exposure of At-Risk Women in the United States
Elizabeth Olarewaju, Emmanuel Obeng-Gyasi
Healthcare (2023) Vol. 11, Iss. 9, pp. 1278-1278
Open Access | Times Cited: 4
Immune checkpoint inhibitors with chemotherapy for primary advanced mismatch repair-deficient endometrial cancer: A cost-effectiveness analysis
Junhwan Kim, Juwon Lim, Shin‐Wha Lee, et al.
Gynecologic Oncology (2023) Vol. 179, pp. 106-114
Open Access | Times Cited: 4
TIGIT: A potential immunotherapy target for gynecological cancers
Siyue Jiang, Wen-Hua Wang, Yongxiu Yang
Pathology - Research and Practice (2024) Vol. 255, pp. 155202-155202
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top